UPI MDR rule could add ₹1.55bn in FY28 revenue for Pine Labs, says Emkay
NPCI’s proposed 0.4% MDR on UPI merchant payments above ₹2,000 could create a new recurring revenue stream for Pine Labs. Emkay Global estimates a ₹51.5bn valuation uplift and has raised its target price to ₹230 from ₹190.
What happened
NPCI’s new 0.4% MDR on higher-value UPI merchant payments could create recurring revenue for Pine Labs. Emkay Global estimates FY28 MDR revenue of ₹1.55
Key facts
- Pine Labs share price: ₹194.45, up 5% intraday
- UPI P2M MDR: 0.4% (40 basis points) for transactions above ₹2,000
- Small-merchant exemption: up to ₹100,000 monthly UPI QR receipts
- MDR allocation: issuer 16 bps, acquirer 12 bps, payer TPAP 8 bps, payer PSP bank 4 bps
- Estimated Pine Labs realised take rate: 6 bps
- Estimated FY28 UPI MDR revenue: ₹1.55 billion
- Estimated valuation addition: ₹51.5 billion, or about ₹43 per share
- Emkay target price: ₹230, raised from ₹190
Why this matters
A UPI MDR regime would strengthen Pine Labs’ strategic value as a merchant-payments platform by creating monetisable transaction economics and potentially making payment-acquisition targets more attractive.
What to watch
- NPCI circular, RBI commentary or government notification specifying MDR rate, transaction threshold, merchant exclusions and implementation date.
- Clarification on whether MDR is paid by merchants, banks, government subsidy mechanisms or other participants in the UPI ecosystem.
- Pine Labs disclosures on UPI payment volume, merchant mix, average ticket size, acquiring economics and expected bps capture.
- Merchant reaction from organized retail, quick-service restaurants, travel, healthcare and other high-ticket categories.
- Competitive pricing actions by payment aggregators, banks and fintech acquirers.
- Evidence that UPI transaction growth remains resilient if merchant payment acceptance costs rise.
- Accelerate onboarding and retention of higher-ticket UPI merchants, especially chains and categories with average transaction values above ₹2,000.
- Bundle payment acceptance, reconciliation, financing and checkout software to defend take rate if MDR economics are shared with merchants or banks.
- Prepare pricing and settlement architecture for transaction-level MDR collection while avoiding merchant churn from abrupt fee changes.
- Use stronger expected recurring revenue visibility to pursue distribution partnerships, cross-sell and potentially lower-cost funding.
- Competitors may intensify merchant-acquisition incentives ahead of implementation, raising sales costs and compressing near-term contribution margins.